Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket studyLingfang Xia, Xiaohua Wu, Jin Peng et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 39
Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.Qinghua Wu, Zhenhe Suo, Claes G. Tropé et al.|PubMed|2014Cited by 6